Differential visceral nociceptive, behavioural and neurochemical responses to an immune challenge in the stress-sensitive Wistar Kyoto rat strain

Behavioural Brain Research

Volumn 253, Issue , 2013, Pages 310-317

  O' Mahony, Siobhain M ^a,b   Clarke, Gerard ^a,b   McKernan, Declan P ^b   Bravo, Javier A ^b   Dinan, Timothy G ^a   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Depression; Irritable bowel syndrome; Lipopolysaccharide; Sickness behaviour; Visceral hypersensitivity; Wistar Kyoto rat

Indexed keywords

CORTICOSTERONE; DOPAMINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NORADRENALIN; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FLUID INTAKE; FOOD INTAKE; HYPERALGESIA; IMMUNE RESPONSE; MALE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; SPRAGUE DAWLEY RAT; STRESS; VISCERAL PAIN; WISTAR KYOTO RAT;

DEPRESSION; IRRITABLE BOWEL SYNDROME; LIPOPOLYSACCHARIDE; SICKNESS BEHAVIOUR; VISCERAL HYPERSENSITIVITY; WISTAR KYOTO RAT;

ANIMALS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; BRAIN CHEMISTRY; CORTICOSTERONE; CYTOKINES; DRINKING; EATING; IMMUNITY; INTERPERSONAL RELATIONS; LIPOPOLYSACCHARIDES; MALE; NOCICEPTION; PAIN THRESHOLD; PHYSICAL STIMULATION; RAPHE NUCLEI; RATS; RATS, INBRED F344; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RECTUM; STRESS, PSYCHOLOGICAL; VISCERAL PAIN;

EID: 84882789805     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.07.023     Document Type: Article

References (69)

1. Courvoisier H., Moisan M.P., Sarrieau A., Hendley E.D., Mormede P. Behavioral and neuroendocrine reactivity to stress in the WKHA/WKY inbred rat strains: a multifactorial and genetic analysis. Brain Research 1996, 743:77-85.
2. Gunter W.D., Shepard J.D., Foreman R.D., Myers D.A., Greenwood-Van Meerveld B. Evidence for visceral hypersensitivity in high-anxiety rats. Physiology and Behavior 2000, 69:379-382.
3. Johnson A.C., Tran L., Schulkin J., Greenwood-Van Meerveld B. Importance of stress receptor-mediated mechanisms in the amygdala on visceral pain perception in an intrinsically anxious rat. Neurogastroenterology and Motility 2012, 24:479-486. e219.
4. O'Malley D., Dinan T.G., Cryan J.F. Interleukin-6 modulates colonic transepithelial ion transport in the stress-sensitive wistar kyoto rat. Frontiers in Pharmacology 2012, 3:190.
5. Rittenhouse P.A., Lopez-Rubalcava C., Stanwood G.D., Lucki I. Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat. Psychoneuroendocrinology 2002, 27:303-318.
6. Gosselin R.D., Gibney S., O'Malley D., Dinan T.G., Cryan J.F. Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression. Neuroscience 2009, 159:915-925.
7. Malkesman O., Weller A. Two different putative genetic animal models of childhood depression-a review. Progress in Neurobiology 2009, 88:153-169.
8. Pare W.P. Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats. Physiology and Behavior 1994, 55:433-439.
9. Gibney S.M., Gosselin R.D., Dinan T.G., Cryan J.F. Colorectal distension-induced prefrontal cortex activation in the Wistar-Kyoto rat: implications for irritable bowel syndrome. Neuroscience 2010, 165:675-683.
10. Pare W.P., Tejani-Butt S.M. Effect of stress on the behavior and 5-HT system in Sprague-Dawley and Wistar Kyoto rat strains. Integrative Physiological and Behavioral Science 1996, 31:112-121.
11. Tejani-Butt S., Kluczynski J., Pare W.P. Strain-dependent modification of behavior following antidepressant treatment. Progress in Neuropsychopharmacology and Biological Psychiatry 2003, 27:7-14.
12. Greenwood-Van Meerveld B., Johnson A.C., Cochrane S., Schulkin J., Myers D.A. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterology and Motility 2005, 17:415-422.
13. O'Mahony S.M., Bulmer D.C., Coelho A.M., Fitzgerald P., Bongiovanni C., Lee K., et al. 5-HT(2B) receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction. Neurogastroenterology and Motility 2010, 22:573-578. e124.
14. Nielsen M.A., Bayati A., Mattsson H. Wistar Kyoto rats have impaired gastric accommodation compared to Sprague Dawley rats due to increased gastric vagal cholinergic tone. Scandinavian Journal of Gastroenterology 2006, 41:773-781.
15. Martinez V., Ryttinger M., Kjerling M., Astin-Nielsen M. Characterisation of colonic accommodation in Wistar Kyoto rats with impaired gastric accommodation. Naunyn-Schmiedeberg's Archives of Pharmacology 2007, 376:205-216.
16. Burke N.N., Hayes E., Calpin P., Kerr D.M., Moriarty O., Finn D.P., et al. Enhanced nociceptive responding in two rat models of depression is associated with alterations in monoamine levels in discrete brain regions. Neuroscience 2010, 171:1300-1313.
17. Suzuki S., Solberg L.C., Redei E.E., Handa R.J. Prepro-thyrotropin releasing hormone 178-199 immunoreactivity is altered in the hypothalamus of the Wistar-Kyoto strain of rat. Brain Research 2001, 913:224-233.
18. Scholl J.L., Renner K.J., Forster G.L., Tejani-Butt S. Central monoamine levels differ between rat strains used in studies of depressive behavior. Brain Research 2010, 1355:41-51.
19. Clarke G., Quigley E.M., Cryan J.F., Dinan T.G. Irritable bowel syndrome: towards biomarker identification. Trends in Molecular Medicine 2009, 15:478-489.
20. Dinan T.G., Quigley E.M., Ahmed S.M., Scully P., O'Brien S., O'Mahony L., et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker. Gastroenterology 2006, 130:304-311.
21. Schmulson M., Chey W.D. Abnormal immune regulation and low-grade inflammation in IBS: does one size fit all. The American Journal of Gastroenterology 2012, 107:273-275.
22. Maes M., Berk M., Goehler L., Song C., Anderson G., Galecki P., et al. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Medicine 2012, 10:66.
23. Leonard B.E. The concept of depression as a dysfunction of the immune system. Current Immunology Reviews 2010, 6:205-212.
24. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews 2008, 9:46-56.
25. O'Malley D., Quigley E.M., Dinan T.G., Cryan J.F. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome?. Brain, Behavior, and Immunity 2011, 25:1333-1341.
26. Laye S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Research. Molecular Brain Research 1994, 27:157-162.
27. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Annals of the New York Academy of Sciences 2001, 933:222-234.
28. Watkins L.R., Wiertelak E.P., Goehler L.E., Mooney-Heiberger K., Martinez J., Furness L., et al. Neurocircuitry of illness-induced hyperalgesia. Brain Research 1994, 639:283-299.
29. Yirmiya R., Rosen H., Donchin O., Ovadia H. Behavioral effects of lipopolysaccharide in rats: involvement of endogenous opioids. Brain Research 1994, 648:80-86.
30. Besedovsky H.O., del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocrine Reviews 1996, 17:64-102.
31. Kent S., Bluthe R.M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., et al. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:9117-9120.
32. Capuron L., Miller A.H. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacology and Therapeutics 2011, 130:226-238.
33. Hart B.L. Biological basis of the behavior of sick animals. Neuroscience and Biobehavioral Reviews 1988, 12:123-137.
34. Kluger M.J., Kozak W., Conn C.A., Leon L.R., Soszynski D. Role of fever in disease. Annals of the New York Academy of Sciences 1998, 856:224-233.
35. Coelho A., Fioramonti J., Bueno L. Brain interleukin-1beta and tumor necrosis factor-alpha are involved in lipopolysaccharide-induced delayed rectal allodynia in awake rats. Brain Research Bulletin 2000, 52:223-228.
36. Coelho A.M., Fioramonti J., Bueno L. Systemic lipopolysaccharide influences rectal sensitivity in rats: role of mast cells, cytokines, and vagus nerve. American Journal of Physiology - Gastrointestinal and Liver Physiology 2000, 279:G781-G790.
37. Tracey I., Dunckley P. Importance of anti- and pro-nociceptive mechanisms in human disease. Gut 2004, 53:1553-1555.
38. O'Mahony C.M., Clarke G., Gibney S., Dinan T.G., Cryan J.F. Strain differences in the neurochemical response to chronic restraint stress in the rat: relevance to depression. Pharmacology Biochemistry and Behavior 2011, 97:690-699.
39. Pearson K.A., Stephen A., Beck S.G., Valentino R.J. Identifying genes in monoamine nuclei that may determine stress vulnerability and depressive behavior in Wistar-Kyoto rats. Neuropsychopharmacology 2006, 31:2449-2461.
40. Connor T.J., Kelly J.P., McGee M., Leonard B.E. Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge. Life Sciences 2000, 67:1601-1612.
41. Frenois F., Moreau M., O'Connor J., Lawson M., Micon C., Lestage J., et al. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007, 32:516-531.
42. O'Mahony S.M., Marchesi J.R., Scully P., Codling C., Ceolho A.M., Quigley E.M., et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biological Psychiatry 2009, 65:263-267.
43. O'Mahony S.M., Tramullas M., Fitzgerald P., Cryan J.F. Rodent models of colorectal distension. Current Protocols in Neuroscience 2012, editorial board, Jacqueline N Crawley [et al]; Chapter 9:Unit9. 40.
44. Kent S., Bret-Dibat J.L., Kelley K.W., Dantzer R. Mechanisms of sickness-induced decreases in food-motivated behavior. Neuroscience and Biobehavioral Reviews 1996, 20:171-175.
45. Bluthe R.M., Walter V., Parnet P., Laye S., Lestage J., Verrier D., et al. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. Comptes Rendus de l'Academie des Sciences 1994, 317:499-503.
46. Castanon N., Bluthe R.M., Dantzer R. Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology 2001, 154:50-60.
47. O'Mahony S., Chua A.S., Quigley E.M., Clarke G., Shanahan F., Keeling P.W., et al. Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model. Neurogastroenterology and Motility 2008, 20:680-688.
48. Seo Y.J., Kwon M.S., Choi H.W., Choi S.M., Nam J.S., Lee J.K., et al. The differential effects of acetaminophen on lipopolysaccharide induced hyperalgesia in various mouse pain models. Pharmacology, Biochemistry, and Behavior 2008, 91:121-127.
49. Hyland N.P., Bongiovanni C., O'Mahony C.M., Fitzgerald P., Dinan T.G., Cryan J.F. The combined effects of neonatal psychological stress and an anxious phenotype on visceral hypersensitivity and colonic function in rats. Gastroenterology 2009, 138(Suppl. 1):A-577.
50. Butler R.K., Finn D.P. Stress-induced analgesia. Progress in Neurobiology 2009, 88:184-202.
51. DaSilva J.K., Lei Y., Madan V., Mann G.L., Ross R.J., Tejani-Butt S., et al. Fear conditioning fragments REM sleep in stress-sensitive Wistar-Kyoto, but not Wistar, rats. Progress in Neuropsychopharmacology and Biological Psychiatry 2011, 35:67-73.
52. Pare W.P., Redei E. Depressive behavior and stress ulcer in Wistar Kyoto rats. Journal of Physiology (Paris) 1993, 87:229-238.
53. Dunn A.J. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. Journal of Pharmacology and Experimental Therapeutics 1992, 261:964-969.
54. Dunn A.J. Effects of cytokines and infections on brain neurochemistry. Clinical Neuroscience Research 2006, 6:52-68.
55. Moyanova S., Ta L. Dorsal raphe stimulation modulates responses of substantia nigra, pars reticulata neurons to painful stimulation. Acta Physiologica et Pharmacologica Bulgarica 1988, 14:24-32.
56. Qiao J.T., Skolnick M., Dafny N. Dorsal raphe and external electrical stimulation modulate noxious input to single neurons in nucleus parafascicularis thalami. Brain Research Bulletin 1988, 21:671-675.
57. Millan M.J. Descending control of pain. Progress in Neurobiology 2002, 66:355-474.
58. Camilleri M., Chey W.Y., Mayer E.A., Northcutt A.R., Heath A., Dukes G.E., et al. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Archives of Internal Medicine 2001, 161:1733-1740.
59. Spiller R. Serotonin, inflammation, and IBS: fitting the jigsaw together?. Journal of Pediatric Gastroenterology and Nutrition 2007, 45(Suppl. 2):S115-S119.
60. Ren T.H., Wu J., Yew D., Ziea E., Lao L., Leung W.K., et al. Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome. American Journal of Physiology - Gastrointestinal and Liver Physiology 2007, 292:G849-G856.
61. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Research 1994, 654:15-26.
62. Benson S., Kattoor J., Wegner A., Hammes F., Reidick D., Grigoleit J.S., et al. Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans. Pain 2012, 153:794-799.
63. Cunha F.Q., Poole S., Lorenzetti B.B., Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. British Journal of Pharmacology 1992, 107:660-664.
64. Watkins L.R., Goehler L.E., Relton J., Brewer M.T., Maier S.F. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Research 1995, 692:244-250.
65. Dinan T.G. Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function. Life Sciences 1996, 58:1683-1694.
66. Browne C.A., O'Brien F.E., Connor T.J., Dinan T.G., Cryan J.F. Differential lipopolysaccharide-induced immune alterations in the hippocampus of two mouse strains: effects of stress. Neuroscience 2012, 225:237-248.
67. Bluthe R.M., Dantzer R., Kelley K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Research 1992, 573:318-320.
68. Bluthe R.M., Pawlowski M., Suarez S., Parnet P., Pittman Q., Kelley K.W., et al. Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology 1994, 19:197-207.
69. Bernard C., Merval R., Esposito B., Tedgui A. Resistance to endotoxin shock in spontaneously hypertensive rats. Hypertension 1998, 31:1350-1356.